Pettee Investors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-8,816
Closed -$875K 121
2019
Q3
$875K Hold
8,816
0.55% 58
2019
Q2
$815K Hold
8,816
0.52% 59
2019
Q1
$832K Hold
8,816
0.52% 59
2018
Q4
$565K Sell
8,816
-1,900
-18% -$140K 0.4% 75
2018
Q3
$959K Sell
10,716
-1,600
-13% -$141K 0.57% 50
2018
Q2
$978K Sell
12,316
-45
-0.4% -$3.74K 0.62% 45
2018
Q1
$1.1M Sell
12,361
-225
-2% -$21.6K 0.68% 39
2017
Q4
$1.31M Sell
12,586
-125
-1% -$14.1K 0.8% 31
2017
Q3
$1.85M Buy
12,711
+300
+2% +$40.9K 1.2% 20
2017
Q2
$1.61M Sell
12,411
-100
-0.8% -$12.3K 1.43% 20
2017
Q1
$1.56M Hold
12,511
1.41% 20
2016
Q4
$1.45M Sell
12,511
-2,200
-15% -$245K 1.38% 22
2016
Q3
$1.54M Sell
14,711
-330
-2% -$35.7K 1.49% 20
2016
Q2
$1.48M Hold
15,041
1.44% 20
2016
Q1
$1.5M Hold
15,041
1.55% 19
2015
Q4
$1.8M Buy
15,041
+2,595
+21% +$300K 1.73% 17
2015
Q3
$1.35M Hold
12,446
1.41% 21
2015
Q2
$1.44M Buy
12,446
+250
+2% +$28.6K 1.4% 21
2015
Q1
$1.41M Hold
12,196
1.36% 22
2014
Q4
$1.36M Hold
12,196
1.31% 24
2014
Q3
$1.16M Sell
12,196
-2,400
-16% -$217K 1.14% 24
2014
Q2
$1.25M Hold
14,596
1.14% 24
2014
Q1
$1.02M Hold
14,596
0.96% 28
2013
Q4
$1.23M Buy
+14,596
New +$1.15M 1.16% 25

Other funds holding CELG

Pettee Investors's CELG Position: Q4 2019 in Review

Pettee Investors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 8,816 shares — an estimated $875K sold.

Pettee Investors first reported a position in CELG in Q4 2013 and held it in 24 quarters. The position peaked at $1.85M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Pettee Investors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Pettee Investors sold 8,816 Celgene Corp shares in Q4 2019, an estimated $875K.
  • Pettee Investors first reported a position in Celgene Corp in Q4 2013 and held it in 24 quarters.
  • Pettee Investors's Celgene Corp position peaked at $1.85M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Pettee Investors's 13F filing for Q4 2019, filed 14 Feb 2020.